USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medipal Holdings Corporation

USPTO PatentsView assignee record - 162 granted patents across 54 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

162

Total patents granted

CPC technology areas

14.3

Avg claims per patent

-54%

5-year filing velocity

The verdict

Medipal holds 162 US patents across 54 technology areas, rank #2,412 of 50,000 tracked assignees.

#2,412
of 50,000 US assignees by volume: Top 7%
by Innovation Score (55.6/100): 14.3
avg claims per patent: -54%
filing velocity, last 5 yrs

Portfolio overview

Medipal Holdings Corporation has been granted 162 US utility patents between 2015 and 2025, placing Medipal Holdings Corporation at rank #2,412 across all assignees tracked by PlainPatent. This portfolio spans 54 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medipal Holdings Corporation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Medipal sits between Embraer S.a. (162 patents, rank #2,408) and Thomas & Betts International Llc (162 patents, rank #2,416) - the closest US assignees by grant volume. The composite Innovation Score of 55.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 51 grants, compared with 111 in the 2015–2019 window, a -54% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medipal Holdings Corporation's 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 54 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medipal Holdings Corporation against peers pursuing similar technology classes.

Embraer

162
Faurecia Interieu…

162
Firestone Industr…

162
Hayward Industries

162
Shiroki

162
SPIN Master

162
Sambanova Systems

162
Thomas & Betts In…

162
Medipal Holdings ◀

162

What this shows Medipal holds 162 patents at rank #2,412, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medipal

By rank, the assignees closest to #2,412 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medipal's primary technology class.

Medipal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medipal Holdings Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	21	13.0%
2016	35	21.6%
2017	21	13.0%
2018	20	12.3%
2019	14	8.6%
2020	11	6.8%
2021	11	6.8%
2022	8	4.9%
2023	5	3.1%
2024	11	6.8%
2025	5	3.1%

Which technologies does Medipal Holdings Corporation patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 84

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 30

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 23

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 14

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 12

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 10

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 8

G06F - ELECTRIC DIGITAL DATA PROCESSING 8

H04H - BROADCAST COMMUNICATION 8

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 6

F16B - DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING 6

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 5

F25D - REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR 5

Top 15 of 54 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,412

Across all tracked assignees

Innovation Score

55.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medipal Holdings Corporation hold?

Medipal Holdings Corporation holds 162 US granted patents filed between 2015 and 2025, spanning 54 technology areas.

What is Medipal Holdings Corporation's Innovation Score?

Medipal Holdings Corporation has an Innovation Score of 55.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medipal Holdings Corporation focus on?

Medipal Holdings Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 84 patents. The company has filed patents in 54 CPC subclasses total.

Is Medipal Holdings Corporation's patent filing rate increasing or decreasing?

Medipal Holdings Corporation's recent filing velocity is -54% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Medipal Holdings Corporation's patents?

Medipal Holdings Corporation's patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Medipal Holdings Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medipal's 162 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Medipal ranks #2,412 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.